Global Health Institute

Health is a fundamental human right and a key factor for human well-being and economic growth. Though, populations in low- and middle-income countries lack availability and access to health solutions.

Launched in April 2017, the Global Health Institute catalyzes innovations for global health challenges. It translates science, technology and digital approaches into transformative health solutions to support prevention, control and elimination programs related to infectious diseases that carry a major toll on the most vulnerable populations: children and women. The diseases in focus are schistosomiasis and malaria. 

As part of the Global Health organisation, the Institute aims to achieve its mission through:

• its research & development (R&D) engine to deliver integrated and top-quality health solutions;
• its efforts to build and/or enhance health capacity and strengthen local health systems;
  
• its support to develop new mechanisms to favor sustainable and equitable access to our innovations.

Applying an integrated approach to combat schistosomiasis and malaria, the Institute’s pipeline includes projects for new treatments, diagnostics, technologies and preventive measures, in addition to initiatives to improve local health capacity mainly in and for Africa. 

Its operating model is based on public-private partnerships with leading global health institutions and organizations, including in low- and middle-income countries.

By doing that, the Institute’s scope is to contribute to the United Nations Sustainable Development Goals (SDGs), especially SDG 3 for good health and well-being, in line with the Company’s Sustainability Strategy.